JPRN-UMIN000008040已完成2 期
A phase 2, open-label study of S-646240 in patients with age-related macular degeneration accompanied by choroidal neovascularization - A phase 2, open-label study of S-646240 in patients with age-related macular degeneration accompanied by choroidal neovascularization
Shionogi & Co., Ltd.0 个研究点目标入组 40 人开始时间: 2012年5月29日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who have CNV due to other causes than age. (2) Patients who have previous or present retinal vessel disease other than AMD.
研究者
相似试验
未知
2 期
A phase 2, open-label study of S-6810 in patients with mycosis fungoides or Sezary syndromeMycosis fungoides or Sezary syndromeJPRN-jRCT2080221783SHIONOGI & CO., LTD.15
未知
2 期
Phase 2 Double-blind Study of S-525606 in Patients with Japanese Cedar Pollinosis Using an Pollen Challenge ChamberJapanese cedar pollinosisJPRN-jRCT2080222876Shionogi & Co., Ltd.
未知
2 期
A Phase 2/3 Study of S-524101 in the Patients with Perennial Allergic RhinitisAllergic rhinitisJPRN-jRCT2080221872SHIONOGI & CO., LTD.
进行中（未招募）
1 期
A Phase 1/2 study of S-268019 (COVID-19)JPRN-jRCT2031210269agata Tsutae60
未知
3 期
An open-label Phase 3 study of S-474474 in patients with essential hypertension - Evaluation of the safety and efficacy of long term useHypertensionJPRN-jRCT2080221437SHIONOGI & CO., LTD.